| [1] |
中华医学会儿科学分会内分泌遗传代谢学组，《中华儿科杂志》编辑委员会．基因重组人生长激素儿科临床规范应用的建议[J]．中华儿科杂志，2013，51(6):426-432.
|
| [2] |
Wilson TA1, Rose SR, Cohen P，et al.Update of guidelines for the use of growth hormone in children：the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee[J]．J Pediatr，2003，143(4):415-421.
|
| [3] |
中华医学会儿科学分会内分泌遗传代谢学组．矮身材儿童诊治指南[J]．中华儿科杂志，2008，46(6):428-430.
|
| [4] |
Growth Hormone Research Society.Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence：summary statement of the GH Research Society.GH Research Society[J]．J Clin Endocrinol Metab，2000，85(11):3990-3993.
|
| [5] |
Gharib H, Cook DM, Saenger PH，et al.American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in adults and children－2003 update[J]．Endocr Pract，2003，9(1):64-76.
|
| [6] |
Cohen P, Rogol AD, Deal CL，et al.Consensus statement on the diagnosis and treatment of children with idiopathic short stature：a summary of the Growth Hormone Research Society，the Lawson Wilkins Pediatric Endocrine Society，and the European Society for Paediatric Endocrinology Workshop[J]．J Clin Endocrinol Metab，2008，93(11):4210-4217.
|
| [7] |
Clayton PE, Cianfarani S, Czernichow P，et al.Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society[J]．J Clin Endocrinol Metab，2007，92(3):804-810.
|
| [8] |
Deal CL, Tony M, Höybye C，et al.GrowthHormone Research Society workshop summary：consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome[J]．J Clin Endocrinol Metab，2013，98(6):1072-1087.
|
| [9] |
Saenger P, Wikland KA, Conway GS，et al.Recommendations for the diagnosis and management of Turner syndrome[J]．J Clin Endocrinol Metab，2001，86(7):3061-3069.
|
| [10] |
Inzaghi E, Cianfarani S．The challenge of growth hormone deficiency diagnosis and treatment during the transition from puberty into adulthood[J]．Front Endocrinol (Lausanne)，2013，20(4):34.
|
| [11] |
Cook DM, Yuen KC, Biller BM，et al.American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients-2009 update：executive summary of recommendations[J]．Endocr Pract，2009，15(6):580-586.
|
| [12] |
Ho KK, GH Deficiency Consensus Workshop Participants.Consensus guidelines for the diagnosis and treatment of adults with GH deficiency Ⅱ：a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology，Lawson Wilkins Society，European Society of Endocrinology，Japan Endocrine Society，and Endocrine Society of Australia[J]．Eur J Endocrinol，2007，157(6):695-700.
|
| [13] |
Molitch ME, Clemmons DR, Malozowski S，et al.Evaluation and treatment of adult growth hormone deficiency：an Endocrine Society clinical practice guideline[J]．J Clin Endocrinol Metab，2011，96(6):1587-1609.
|
| [14] |
Clayton PE, Cuneo RC, Juul A，et al.Consensus statement on the management of the GH-treated adolescent in the transition to adult care[J]．Eur J Endocrinol，2005，152(2):165-170.
|
| [15] |
Bell J, Parker KL, Swinford RD，et al.Long-term safety of recombinant human growth hormone in children[J]．J Clin Endocrinol Metab，2010，95(1):167-177.
|
| [16] |
Bell J, Parker KL, Swinford RD，et al.Recurrence of brain tumours in patients treated with growth hormone：analysis of KIGS (Pfizer International Growth Database)[J]．Acta Paediatr，2006，95(10):1284-1290.
|
| [17] |
Swerdlow AJ, Higgins CD, Adlard P，et al.Risk of cancer in patients treated with human pituitary growth hormone in the UK，1959-85：a cohort study[J]．Lancet，2002，360(9329):273-277.
|